XTX Topco’s NeoGenomics NEO Stock Holding History

XTX Topco’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41M	Buy	96,885 +60,473	+166%	+$584K	0.02%	1462
2026 Q1	$270K	Buy	+36,412	New	+$383K	﹤0.01%	2569
2025 Q4	–	Sell	-26,247	Closed	-$203K	–	3635
2025 Q3	$203K	Buy	+26,247	New	+$184K	0.01%	1837
2023 Q4	–	Sell	-12,765	Closed	-$157K	–	1932
2023 Q3	$157K	Buy	12,765 +504	+4%	+$7.5K	0.03%	1094
2023 Q2	$197K	Buy	+12,261	New	+$202K	0.04%	1017
2022 Q4	–	Sell	-14,494	Closed	-$125K	–	1372
2022 Q3	$125K	Buy	+14,494	New	+$144K	0.03%	904
2021 Q2	–	Sell	-8,529	Closed	-$411K	–	997
2021 Q1	$411K	Buy	+8,529	New	+$444K	0.2%	153

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

XTX Topco's NEO Position: Q2 2026 in Review

XTX Topco increased its NeoGenomics (NEO) stake by 166% in Q2 2026, buying an estimated $584K and bringing the position to 96,885 shares worth $1.41M. The position accounts for 0.02% of the portfolio, ranked #1462.

XTX Topco first reported a position in NEO in Q1 2021 and has held it in 7 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

XTX Topco held 96,885 shares of NeoGenomics worth $1.41M as of Q2 2026.
XTX Topco bought 60,473 NeoGenomics shares in Q2 2026, an estimated $584K.
NeoGenomics made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1462 holding.
XTX Topco first reported a position in NeoGenomics in Q1 2021 and has held it in 7 quarters since.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.